Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.06B |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$758M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$666M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$433M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$386M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$210M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$144M |
Sector Composition
| 1 | Technology | 12.48% |
| 2 | Healthcare | 11.39% |
| 3 | Financials | 9.24% |
| 4 | Communication Services | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
876
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.69M | ﹤0.01% |
44,493
+10,654
| +31% | +$884K |
|
877
Restaurant Brands International
QSR
$20.7B
| $3.68M | ﹤0.01% |
65,986
+34,479
| +109% | +$1.92M |
|
878
AngloGold Ashanti
AU
$32.6B
| $3.68M | ﹤0.01% |
341,504
+97,127
| +40% | +$1.05M |
|
|
BPT
879
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $3.67M | ﹤0.01% |
182,321
+178,172
| +4,294% | +$3.58M |
|
|
CIM
880
Chimera Investment
CIM
$1.18B
| $3.66M | ﹤0.01% |
60,482
-4,470
| -7% | -$271K |
|
881
lululemon athletica
LULU
$19.7B
| $3.66M | ﹤0.01% |
70,545
+3,209
| +5% | +$166K |
|
882
Keysight
KEYS
$29.5B
| $3.65M | ﹤0.01% |
101,115
+94,729
| +1,483% | +$3.42M |
|
883
Celestica
CLS
$28.5B
| $3.63M | ﹤0.01% |
250,041
+76,313
| +44% | +$1.11M |
|
884
SITE Centers
SITC
$474M
| $3.62M | ﹤0.01% |
224,547
+170,822
| +318% | +$2.76M |
|
885
Check Point Software Technologies
CHKP
$21.1B
| $3.62M | ﹤0.01% |
35,281
-16,605
| -32% | -$1.71M |
|
886
Adient
ADNT
$1.98B
| $3.62M | ﹤0.01% |
49,782
+8,874
| +22% | +$645K |
|
887
3D Systems Corporation
DDD
$287M
| $3.62M | ﹤0.01% |
241,869
-50,103
| -17% | -$749K |
|
|
VAL
888
DELISTED
Valspar
VAL
| $3.61M | ﹤0.01% |
32,508
+21,484
| +195% | +$2.38M |
|
|
ANSS
889
DELISTED
Ansys
ANSS
| $3.6M | ﹤0.01% |
33,644
+10,660
| +46% | +$1.14M |
|
|
RSX
890
DELISTED
VanEck Russia ETF
RSX
| $3.59M | ﹤0.01% |
173,853
-6,080
| -3% | -$126K |
|
|
SABA
891
Saba Capital Income & Opportunities Fund II
SABA
$255M
| $3.59M | ﹤0.01% |
+270,084
| New | +$3.59M |
|
|
GBT
892
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.59M | ﹤0.01% |
97,380
+70,057
| +256% | +$2.58M |
|
893
New Oriental
EDU
$8.96B
| $3.56M | ﹤0.01% |
58,874
-10,783
| -15% | -$651K |
|
894
Radian Group
RDN
$4.82B
| $3.54M | ﹤0.01% |
197,058
-4,549
| -2% | -$81.7K |
|
|
TIVO
895
DELISTED
Tivo Inc
TIVO
| $3.53M | ﹤0.01% |
188,214
-82,996
| -31% | -$1.56M |
|
|
LPT
896
DELISTED
Liberty Property Trust
LPT
| $3.53M | ﹤0.01% |
91,417
+11,526
| +14% | +$444K |
|
897
Lattice Semiconductor
LSCC
$9.01B
| $3.52M | ﹤0.01% |
508,688
+183,225
| +56% | +$1.27M |
|
|
EFII
898
DELISTED
Electronics for Imaging
EFII
| $3.51M | ﹤0.01% |
71,895
+36,936
| +106% | +$1.8M |
|
|
CDK
899
DELISTED
CDK Global, Inc.
CDK
| $3.51M | ﹤0.01% |
53,933
-20,935
| -28% | -$1.36M |
|
900
Brookfield
BN
$104B
| $3.5M | ﹤0.01% |
179,569
+58,949
| +49% | +$1.15M |
|